EU IMPD vs. US IND: Comparing the Content and Agency Expectations
September 21, 2010(Ended)
Online Webinar
This training on EU IMPD & US IND will help you in understanding the clinical trial and registration / licensing differences between US and EU as per EU IMPD and US IND and cover the guidance document explaining data expectations in Phase I, II, III and licensing.Learning Objectives:
- This course is designed to provide an overview of the Clinical Trial start-up procedures by area and then move into the dossier requirement differences between the U.S. and across the EU.
- Guidance documents will be reviewed which highlight the EU expectations of the IMP whether a sponsor is entering a clinical trial or filing for licensing.
- This Course will give both a good detailed overview of clinical trial and registration processes and dig into the technical details expected by FDA and the Competent Authorities across the EU.
- US FDA and EU Agency Orientation / Structure.
- Start –Up and Conducting Clinical Trial Processes.
- Following Product Registration / Licensing Options.
- Company Strategy- Linking Clinical Trials & Marketing Authorization Applications.
- Balancing Strategy and Long Term Regulatory Cost & Maintenance.
- IMP Dossier & Comparisons of the US IND to the EU CTA Content.
- Scientific Advice: Member States vs. Pre-IND Meetings with U.S. FDA.
- Orphan Drugs: EU vs. US Treatment.
- GCP Compliance Inspections.
- Essentially Similar and Generic Products.
- Cross-Agency Interactions: Comparing U.S. FDA and EMA.
- Effective Interactions with the Global Regulatory Healthcare Authorities.
- Helpful Websites.
- Glossary of Terms.
Prices *
249 US Dollar
Exhibition
No exhibition
Organization
Categories
Concurrent events
- Why Medical Device Companies Receive Warning Letters - Webinar by GlobalCompliancePanel 2010
- Quality by Design (QbD) and Analytical Methods - Webinar by GlobalCompliancePanel 2010
- Auditing Computer System Validation Materials - Webinar by GlobalCompliancePanel 2010
- ComplianceOnline Webinar - Medical Device Changes and The 510(k) 2010
- What are the “Good Clinical Practices” (GCP) of Research involving Human Subjects
- Service Level Agreements (SLAs) - Preparation Guidelines for Effective SLAs
- Developing Supplier Quality Auditor Training Programs
- Project Management Certification Study Group - Information Year 2010
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Attending Health conferences is beneficial not only for professionals
- Science conference and seminars
- Determine the prevalence of hypermetropia among young male and female
- Cancer Basic Research
- Chronic lymphocytic leukemia and related disorders - Clinical
- Validation of Palliative Prognostic Index for Terminal Cancer Patients in Hospice Consultation Setting in Taiwan
